Samuel S Ahn insider trades: U.S. Stem Cell (BHRT.OB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Samuel reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2015 | BHRT.OB | ↑ Buy | 2,994,012 | $0.01 | $20K | Direct | May 26, 2015 (4d) |
| Sep 30, 2013 | BHRT.OB | ↑ Buy | 8,771,929 | $0.01 | $123K | Direct | Mar 14, 2014 (165d) |
| Jul 10, 2012 | BHRT.OB | ↑ Buy | 2,500,000 | $0.03 | $75K | Direct | Mar 14, 2014 (612d) |
| Jan 30, 2012 | BHRT.OB | ↑ Buy | 5,500,000 | $0.02 | $110K | Direct | Feb 3, 2012 (4d) |
| Dec 1, 2011 | BHRT.OB | ↑ Buy | 1,084,200 | $0.05 | $54K | Direct | Dec 7, 2011 (6d) |
| Nov 8, 2011 | BHRT | ↑ Buy | 2,500,000 | $0.04 | $100K | Direct | Nov 14, 2011 (6d) |
| Apr 6, 2011 | BHRT | ↑ Buy | 675,070 | $0.15 | $100K | Direct | Apr 6, 2011 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Samuel S Ahn's insider trades
Samuel S Ahn is a director at U.S. Stem Cell (BHRT.OB). Since Apr 6, 2011, Samuel has reported 7 open-market purchases worth $582K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BHRT.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.